Navigation Links
Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
Date:12/9/2010

BETHESDA, Md., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested (2.5, 5.0, and 7.5 g TID), with the 2.5 and 5.0 g doses producing similar responses to one another, and the 7.5 g dose producing a greater response.

In addition, by the end of the six-month trial, the 7.5 g dose reduced serum triglycerides vs. the 2.5 g dose by -42 mg/dl from a mean of 180 mg/dl in the Evaluable Efficacy (EE) population. The reduction in serum triglycerides became statistically significant in the Intent-To-Treat (ITT) population at three months of treatment (-31 mg/dl, p=0.03) and the reduction essentially held steady at the six-month end-of-study visit (-29 mg/dl).

In the single-blind study designed to establish the minimum dose capable of causing a beneficial effect, three different doses of D-tagatose were administered to patients orally with meals TID. The comparator was the 2.5 g dose. The study was designed with a minimum of 34 patients in each of the three groups for a total of 102 evaluable patients. The primary endpoint for the study was reduction in HbA1c after six months of treatment. In the minimum dose range, D-tagatose produced a -0.3% reduction in HbA1c in the 7.5 g dose group vs. the 2.5 g dose group in the EE population, from a mean randomization HbA1c of 7.4%. The reduction of the 7.5 g dose was 0.2% more than the 2.5 g dose in the ITT population.

Unlike
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
2. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
3. Spherix Announces Closing of Institutional Investors Purchase of $5.25 Million of Convertible Preferred Stock and Warrants
4. Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes
5. Spherix Announces Second Quarter 2010 Financial Results
6. Spherix Announces the Closing of $6.3 Million Registered Direct Offering
7. Spherix Announces Results of Annual Shareholders Meeting
8. Spherix Incorporated Announces Annual Shareholders Meeting Date
9. Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development
10. Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
11. Spherix Reports Second Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life ... products for advanced microarray diagnostics, today announced it will ... at 2:00 pm ET.  During the ... brief review of SQI,s recent commercialization progress and then ... veteran recently appointed to the Board of Directors of ...
(Date:8/18/2014)... August 18, 2014 According ... Market Research "Life Science Reagents Market(Products- PCR Reagent ... Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- ... Clinical Laboratories, and Forensic Laboratories)- Global Industry Analysis, ... 2019", the global life science reagents market was ...
(Date:8/18/2014)... 2014 Vier führende deutsche Augenzentren ... Studie auf, in der eine Intraokularlinse (IOL) ... Sehvermögen bei allen Entfernungen verbessern, so dass ... Lese- oder Gleitsichtbrille mehr benötigen. Die neue ... Accommodating Intraocular Lens (FluidVision akkomodative Intraokularlinse) ...
(Date:8/15/2014)... LAKE FOREST, Ill. , Aug. 15, 2014 /PRNewswire/ ... the world,s leading provider of injectable drugs and infusion ... the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. ... The presentation is scheduled to begin at ...  It will be available to all interested parties through ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... BioLife Solutions, Inc.,(OTC Bulletin Board: BLFS), a ... storage and cryopreservation media products for cells,tissues, ... Rutgers University Cell and DNA,Repository (RUCDR), ... the Company,s CryoStor as the exclusive cryopreservation ...
... Doubles Manufacturing Capacity; Expands Global Reach with Vietnam ... Alpine Biomed Corporation, a global leader in ... doubled its manufacturing capacity and expanded its worldwide ... The company will produce and distribute medical devices ...
... Conference Call Scheduled for 5:00 p.m. ETORANGE COUNTY, Calif., ... BEC ) announced today it will host a conference ... ET to discuss the company,s first quarter 2009 results. ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )The call may be accessed by ...
Cached Biology Technology:Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 2Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media 3Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 2Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices 3Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes 2
(Date:8/19/2014)... Ill. A new study of 9- and 10-year-olds ... more fibrous and compact white-matter tracts in the brain ... describes the bundles of axons that carry nerve signals ... matter is associated with faster and more efficient nerve ... the open-access journal Frontiers in Human Neuroscience. , ...
(Date:8/18/2014)... 2014 ,Trustonic TEE ... smart devices  Trustonic, the leading provider ... and Fingerprint Cards AB (FPC) today announced a ... secure biometric authentication on connected devices. ... (FPC1020, FPC1021 and FPC1150) and sensor driver software ...
(Date:8/18/2014)... a new satellite image of Antarctica, and the imagery ... insight into the effects of climate change. , Thanks ... MacDonald, Dettwiler and Associates Ltd. (MDA), the prime contractor ... Network (CCIN) at UWaterloo, the mosaic is free and ... , Using Synthetic Aperture Radar with multiple polarization ...
Breaking Biology News(10 mins):Physically fit kids have beefier brain white matter than their less-fit peers 2Physically fit kids have beefier brain white matter than their less-fit peers 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Waterloo makes public most complete Antarctic map for climate research 2
... edible dormice ( Glis glis ) are busy caring for ... to replenish their fat stores to cope with the upcoming ... pleasant taste and dormice have long been viewed as a ... fatten them up for eating, which explains the "edible" part ...
... pioneering online biology video sites, iBioSeminars and iBioMagazine, have ... with even more to offer the biology community. Following ... provide videos by world-class biologists for free. ... broad audience, says iBiology Director Sarah Goodwin PhD, including ...
... 2013 A study performed at Children,s Hospital Los Angeles ... children with optic nerve hypoplasia (ONH). Their results are reported ... Ophthalmology and Strabismus ( AAPOS ). ONH, an ... appear either as an isolated abnormality or as part of ...
Cached Biology News:Fat and fit 22 online science video pioneers combine to form new iBiology.org 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 2No evidence to support stem cell therapy for pediatric optic nerve hypoplasia 3
... Physical Form: buffered aqueous solution. ... terminal galactose from complex carbohydrates and glycoproteins. ... galactose under conditions where the pH must ... live cells. Unit Definition: ...
... for human cardiac troponin subunit T, a 31kDa ... for contraction of cardiac muscle. It reacts with ... cells. It also cross-reacts with human skeletal troponin ... Highly purified human cardiac troponin T ...
cystatin A (N-18)...
... to offer the ATTO-TAG series of ... primary amines. Developed by Novotny and ... reagents are similar to the important ... anthracene-2,3-dicarboxaldehyde, all of which are also ...
Biology Products: